Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

NCT03185793 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: Placebo
DRUG: SHR4640
DRUG: benzbromarone

Sponsor

Jiangsu HengRui Medicine Co., Ltd.